January 22, 2019

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis

Aurinia Pharmaceuticals (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced positive results for its...
October 16, 2018

Pharmaceutical Update: Q3 2018 in Review

With Q3 behind us and Q4 already in full swing, the Investing News Network is providing a look at some...
October 9, 2016

5 Top NASDAQ Biotech Stocks: Aurinia Pharmaceuticals Up 90 Percent Year-To-Date

Last week's top gainer was Aurinia Pharmaceuticals, followed by Neptune Tech & Bioresources, Madrigal Pharmaceuticals, Biodel and Curis